Cliff Asness's GMAB Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 82,227 shares of Genmab A/S (GMAB) worth $2.53 M, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Cliff Asness has maintained this position in GMAB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 43,738 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Genmab A/S (GMAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Genmab A/S (GMAB) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +8,526 | Add 11.57% | 82,227 | $30.80 |
| Q3 2025 | +43,738 | Add 145.97% | 73,701 | $30.67 |
| Q2 2025 | +29,963 | New Buy | 29,963 | $20.66 |
Cliff Asness's Genmab A/S Investment FAQs
Cliff Asness first purchased Genmab A/S (GMAB) in Q2 2025, acquiring 29,963 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Genmab A/S (GMAB) for 3 quarters since Q2 2025.
Cliff Asness's largest addition to Genmab A/S (GMAB) was in Q3 2025, adding 73,701 shares worth $2.26 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 82,227 shares of Genmab A/S (GMAB), valued at approximately $2.53 M.
As of the Q4 2025 filing, Genmab A/S (GMAB) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Genmab A/S (GMAB) was 82,227 shares, as reported at the end of Q4 2025.